Article
Identification of a novel subpopulation of tumor-initiating cells from gemcitabine-resistant pancreatic ductal adenocarcinoma patients.
PloS one - 1 Jan 2013
Shimizu Kazuya, Chiba Sachie, Hori Yuichi
Abstract excerpt
Pancreatic ductal adenocarcinoma is highly resistant to systemic chemotherapy. Although there are many reports using pancreatic cancer cells derived from patients who did not receive chemotherapy, characteristics of pancreatic cancer cells from chemotherapy-resistant patients remain unclear. In this study, we set out to establish a cancer cell line in disseminated cancer cells derived from gemcitabine-resistant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
